[HTML][HTML] Radiofrequency ablation in Barrett's esophagus with dysplasia

…, GW Falk, MB Kimmey, RD Madanick… - … England Journal of …, 2009 - Mass Medical Soc
Background Barrett's esophagus, a condition of intestinal metaplasia of the esophagus, is
associated with an increased risk of esophageal adenocarcinoma. We assessed whether …

Durability of radiofrequency ablation in Barrett's esophagus with dysplasia

…, SR Gordon, SA Edmundowicz, RD Madanick… - Gastroenterology, 2011 - Elsevier
BACKGROUND & AIMS: Radiofrequency ablation (RFA) can eradicate dysplasia and
intestinal metaplasia in patients with dysplastic Barrett's esophagus (BE), and reduce rates of …

Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis

…, M Ivanovic, A Chau, JT Woosley, RD Madanick… - Gastroenterology, 2012 - Elsevier
We performed a randomized trial to compare nebulized and viscous topical corticosteroid
treatments for eosinophilic esophagitis (EoE). Subjects with incident EoE (n = 25) received …

A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or …

…, S Malone, ES Dellon, RD Madanick… - The Journal of …, 2016 - academic.oup.com
Background. A novel translational pharmacology investigation was conducted by combining
an in vitro efficacy target with mucosal tissue pharmacokinetic (PK) data and mathematical …

Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing …

…, K Woodward, JH Gebhart, RD Madanick… - Official journal of the …, 2013 - journals.lww.com
OBJECTIVES: Proton-pump inhibitor-responsive esophageal eosinophilia (PPI-REE) is a
newly recognized entity that must be differentiated from eosinophilic esophagitis (EoE). Little is …

A cost-utility analysis of ablative therapy for Barrett's esophagus

JM Inadomi, M Somsouk, RD Madanick, JP Thomas… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: Recommendations for patients with Barrett's esophagus (BE)
include endoscopic surveillance with esophagectomy for early-stage cancer, although new …

Randomised clinical trial: high‐dose acid suppression for chronic cough–a double‐blind, placebo‐controlled study

…, SD Crockett, SD Bright, RD Madanick… - Alimentary …, 2011 - Wiley Online Library
… Dr Madanick is on the speakers’ bureau and has received honoraria from Astra Zeneca. Dr
Dellon has received research support from Astra Zeneca. Dr Morgan has received research …

Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications

…, TC Rubinas, KJ Fritchie, RD Madanick… - Gastrointestinal …, 2010 - Elsevier
BACKGROUND: Esophageal strictures resulting from eosinophilic esophagitis present
management challenges, and high rates of rents and perforation have been reported. OBJECTIVE…

Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus

…, CC Cotton, S Pasricha, RD Madanick… - Clinical …, 2013 - Elsevier
BACKGROUND & AIMS: The goal of radiofrequency ablation (RFA) for patients with Barrett's
esophagus (BE) is to eliminate dysplasia and metaplasia. The efficacy and safety of RFA for …

Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation

…, MB Spacek, X Chen, RD Madanick… - Official journal of the …, 2013 - journals.lww.com
OBJECTIVES: Radiofrequency ablation (RFA) of Barrett's esophagus (BE) is safe and effective
in eradicating dysplasia and intestinal metaplasia, and may reduce rates of esophageal …